breath share gain
strong result robust mask perform report solid
result underli ebit yoy cs estim
non-gaap ep yoy higher cs
estim takeaway includ strong mask growth
us row respect us devic growth
continu uptak aissens gross margin bp
prior year benefit manufacturing/procur effici
product mix chang higher contribut saa record one-
litig restructur cost
gain share view benefit broadest
product portfolio launch three new mask
past month excess peer limit new competit
pressur horizon short term vitera expect
lengthi roll-out us next month present
opportun share gain stabl price environ
next round competit bid rate come effect
forecast continu strong growth us mask devic
respect
maintain outperform rate increas target price
due dcf model roll-forward ep upgrad across
forecast period trade cs revis ep ahead
two-year averag premium market
increas invest data platform remain upbeat
abil use data improv qualiti care patient home
set increas penetr rate within sleep copd market
note current forecast includ addit upsid recent
catalysts/risk integr recent acquisit competitor product
valuat metric
chang previou ep
price month
total return forecast perspect
suiss seek busi compani cover research report result investor awar
firm may conflict interest could affect object report investor consid report
singl factor make invest decis
price book
return equiti
return asset
return invest cap
net debt ebitda
capital-expenditure sale
capital-expenditure depr
price jul rate outperform target price analyst gretel janu
profit tax
profit tax
unusu item tax
chang work capit
cash non-cash item
movement cash/equival
 asx close
spot exchang rate
net interest
net profit tax
sale divis
gross margin consist
sg a/sal higher end trend toward lower
end
revenu yoy cs forecast
manag note continu take share healthcar provid
physician choos script continu uptak
revenu yoy cs forecast cycl strong comp
mask continu good traction strong launch new
mask continu re-suppli growth
saa benefit acquisit expect double-digit growth
saa revenu yoy
saa revenu aid full quarter contribut matrixcar healthcar
first acquisit base brightre busi grew high singl digit rang
matrixcar low double-digit rang
manag expect saa achiev double-digit growth medium term
row devic still cycl chang reimburs franc
still cycl upgrad chang franc japan reimburs
continu gain traction mask categori get benefit recent
gross margin improv higher proport saa revenu
gross profit cs forecast gross margin
bp vs prior quarter matrixcar bp accret
gross margin remaind benefit due manufactur effici
favour product mix partial off-set typic asp declin
sg exclud acquisit sg would cc
sg percentag revenu improv ahead cs estim
 vs pcp ex acquisit revenu
bp cs forecast
earn dividend
non-gaap ep ahead cse
quarterli dividend line forecast
incorpor number chang forecast follow result
revenu increas us mask growth assum continu market share gain
decreas estim row devic assum still impact
chang reimburs franc japan assum saa grow double-
digit medium term
gross margin minor reduct gross margin assum
improv mix shift saa
sg assum abl achiev greater oper leverag vs
verili jv increas verili jv loss previous
currenc updat cs in-hous currenc forecast relev fx exposur
aggreg increas non-gaap ep estim averag
forecast period dcf-deriv target price increas due model roll-
forward increas earn maintain outperform rate
current trade cs revis forward price-to-earnings repres
premium rel industri ex-financi two-year averag
respect
figur long-term multipl
figur trade premium market
price-to-earnings multipl rel xji ex-financi
chart bloomberg credit suiss estim
net interest
net profit tax
figur us group revenu
revenu composit segment
revenu segment us mn
figur us driven revenu
revenu segment us mn
figur us mask growth remain strong
revenu growth segment cc
figur gross margin yoy
figur yoy
cost revenu
chart compani data credit suiss estim
figur us growth pick
figur gener account sale figur forecast shift mask
mix sale
chart compani data credit suiss estim
new total return forecast perspect chart help visual credit suiss consensu view compani return within
context forecast risk histor trade pattern
volatil calcul annualis standard deviat weekli total return seri past month illustr variabl
stock return word risk way think one would rather take forecast return stock volatil
stock volatil shade area show one standard deviat rang base past month volatil statist
term make number brave assumpt probabl share price end insid rang month
hi-lo maximum minimum daili close price past week often handi know price momentum especi
stock trade close high low stock trade close peak momentum stock
consensu consensu suppli thomson reuter survey sell side research analyst collect dozen data
point ep dp sale target price roe mean averag target return shade area around mean
repres rang estim lowest highest estim aid visualis number import factor rang
analyst estim credit suiss estim stock sit rel consensu share price rel consensu
mean consensu rang target
return calcul capit gain plu forecast dividend yield net next month cs tgt use credit suiss
target price credit suiss forecast forward dividend gross frank consensu mean rang use
consensu target price consensu dividend forecast month forward
charl martineau pm univers toronto compani mention price
